Successful treatment with alectinib after crizotinib-induced esophageal ulceration. Issue 3 (June 2015)

• Record Type: Journal Article
• Authors: Yoneshima, Yasuto; Okamoto, Isamu; Takano, Tomotsugu; Enokizu, Aimi; Iwama, Eiji; Harada, Taishi; Takayama, Koichi; Nakanishi, Yoichi
• Is Part Of: Lung cancer. Volume 88:Issue 3(2015:Jun.)
• Page Start: 349
• Page End: 351
• Publication Date: 2015-06
• Subjects: Lungs -- Cancer -- Periodicals; Lung Neoplasms -- Abstracts; Lung Neoplasms -- Periodicals; Poumons -- Cancer -- Périodiques; Lungs -- Cancer; Periodicals; Electronic journals; Electronic journals; 616.99424
• DOI: 10.1016/j.lungcan.2015.03.012
• Languages: English
• ISSNs: 0169-5002

Abstract

<abstract abstract-type="author-highlights" id="abs0005"> <title id="sect0005">Highlights</title> <sec> <p id="spar0005"> <list id="lis0005"> <list-item id="lsti0005"> <label></label> <p id="par0005">Esophageal injury has been reported as an adverse event associated with crizotinib.</p> </list-item> <list-item id="lsti0010"> <label></label> <p id="par0010">Alectinib is a highly selective ALK inhibitor and was approved in Japanin 2014.</p> </list-item> <list-item id="lsti0015"> <label></label> <p id="par0015">We describe the treatment with alectinib after crizotinib-induced esophageal ulcer.</p> </list-item> </list> </p> </sec> </abstract>